Skip to main content

Advertisement

Log in

Predictive Power of Biomarkers of Oxidative Stress and Inflammation in Patients with Hepatitis C Virus-Associated Hepatocellular Carcinoma

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

This study evaluated the relationship between inflammation, intra-hepatic oxidative stress, oxidative DNA damage and the progression of liver carcinogenesis in hepatitis C virus (HCV)-infected humans.

Methods

Non-cancerous liver tissues were collected from 30 patients with an HCV-associated solitary hepatocellular carcinoma (HCC) who received curative tumor removal. After surgery, the patients were followed at monthly intervals at the outpatient clinic. Distribution of the inflammatory cells (CD68+), the number of 8-hydroxydeoxyguanosine (8-OHdG) DNA adducts and 4-hydroxynonenal (HNE) protein adducts and the expression of apurinic/apyrimidinic endonuclease (APE) were determined by immunohistochemical analysis in serial liver sections from tumor-free parenchyma at the surgical margin around the tumor.

Results

Significant positive correlations were observed between the number of CD68+ cells, the amount of HNE protein adducts, and the number of 8-OHdG adducts in liver tissue of patients with HCC and HCV. The cumulative disease-free survival was significantly shorter in patients with the highest percentage of 8-OHdG-positive hepatocytes. Using a Cox proportional hazard model, 8-OHdG, HNE and CD68 were determined to be good biomarkers for predicting disease-free survival in patients with HCC and HCV.

Conclusions

These results support the hypothesis that HCV-induced inflammation causes oxidative DNA damage and promotes hepatocarcinogenesis which directly affects the clinical outcome. Since patients with greater intra-hepatic oxidative stress had a higher incidence of HCC recurrence, we suggest that oxidative stress biomarkers could potentially be used as a useful clinical diagnostic tool to predict the duration of disease-free survival in patients with HCV-associated HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1.
FIG. 2.
FIG. 3.
FIG. 4.
FIG. 5.

Similar content being viewed by others

References

  1. Inoue H, Seitz HK. Viruses and alcohol in the pathogenesis of primary hepatic carcinoma. Eur J Cancer Prev 2001; 10:107–110

    Article  PubMed  CAS  Google Scholar 

  2. Kountouras J, Lygidakis NJ. New epidemiological data on liver oncogenesis. Hepatogastroenterology 2000; 47:855–861

    PubMed  CAS  Google Scholar 

  3. Higuchi M, Tanaka E, Kiyosawa K. Epidemiology and clinical aspects on hepatitis C. Jpn J Infect Dis 2002; 55:69–77

    PubMed  Google Scholar 

  4. Idilman R, De Maria N, Colantoni A, Van Thiel DH. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J Viral Hepat 1998; 5:285–299

    Article  PubMed  CAS  Google Scholar 

  5. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3:276–285

    Article  PubMed  CAS  Google Scholar 

  6. De Maria N, Colantoni A, Fagiuoli S, et al. Association between reactive oxygen species, disease activity in chronic hepatitis C. Free Radic Biol Med 1996; 21:291–295

    Article  PubMed  Google Scholar 

  7. Cahill BA, Braccia D. Current treatment for hepatocellular carcinoma. Clin J Oncol Nurs 2004; 8:393–399

    PubMed  Google Scholar 

  8. Matsumoto K, Yoshimoto J, Sugo H, Kojima K, Futagawa S, Matsumoto T. Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C. Hepatol Res 2002; 23:196–201

    Article  PubMed  Google Scholar 

  9. Matsumoto K, Satoh Y, Sugo H, et al. Immunohistochemical study of the relationship between 8-hydroxy-2’-deoxyguanosine levels in noncancerous region and postoperative recurrence of hepatocellular carcinoma in remnant liver. Hepatol Res 2003; 25:435–441

    Article  PubMed  CAS  Google Scholar 

  10. Grune S, Michl M, Schinharl D, et al. Rapid effects of lipopolysaccharides on indocyanine green clearance in rat liver. Eur J Gastroenterol Hepatol 2000; 12:679–685

    Article  PubMed  CAS  Google Scholar 

  11. Poeze M, Ramsay G, Buurman WA, Greve JW, Dentener M, Takala J. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock 2002; 17:451–458

    Article  PubMed  Google Scholar 

  12. Rusyn I, Asakura S, Pachkowski B, et al. Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: Identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res 2004; 64:1050–1057

    Article  PubMed  CAS  Google Scholar 

  13. Cairns J. The contribution of bacterial hypermutators to mutation in stationary phase. Genetics 2000; 156:923–926

    PubMed  CAS  Google Scholar 

  14. Hofseth LJ, Khan MA, Ambrose M, et al. The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J Clin Invest 2003; 112:1887–1894

    Article  PubMed  CAS  Google Scholar 

  15. Hothorn T, Lausen B, Benner A, Radespiel-Troger M. Bagging survival trees. Stat Med 2004; 23:77–91

    Article  PubMed  Google Scholar 

  16. Lai MM. Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 2002; 122:568–571

    Article  PubMed  Google Scholar 

  17. Murakami T, Kim T, Nakamura H. Hepatitis, cirrhosis, and hepatoma. J Magn Reson Imaging 1998; 8:346–358

    Article  PubMed  CAS  Google Scholar 

  18. Okuda M, Li K, Beard MR, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122:366–375

    Article  PubMed  CAS  Google Scholar 

  19. Korenaga M, Wang T, Li Y, et al. Hepatitis C Virus Core Protein Inhibits Mitochondrial Electron Transport and Increases Reactive Oxygen Species (ROS) Production. J Biol Chem 2005; 280:37481–37488

    Article  PubMed  CAS  Google Scholar 

  20. Okada S, Shimada K, Yamamoto J, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106:1618–1624

    PubMed  CAS  Google Scholar 

  21. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238:703–710

    Article  PubMed  Google Scholar 

  22. Adachi E, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108:768–775

    Article  PubMed  CAS  Google Scholar 

  23. Chen YJ, Yeh SH, Chen JT, et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000; 119:431–440

    Article  PubMed  CAS  Google Scholar 

  24. Iizuka N, Oka M, Yamada-Okabe H, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003; 361:923–929

    Article  PubMed  CAS  Google Scholar 

  25. Kurokawa Y, Matoba R, Takemasa I, et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol 2004; 41:284–291

    Article  PubMed  CAS  Google Scholar 

  26. Smith MW, Yue ZN, Korth MJ, et al. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology 2003; 38:1458–1467

    PubMed  CAS  Google Scholar 

  27. Llovet JM, Wurmbach E. Gene expression profiles in hepatocellular carcinoma: not yet there. J Hepatol 2004; 41:336–339

    Article  PubMed  CAS  Google Scholar 

  28. Schwarz KB, Kew M, Klein A, et al. Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma. Dig Dis Sci 2001; 46:2173–2178

    Article  PubMed  CAS  Google Scholar 

  29. Wanibuchi H, Hori T, Meenakshi V, et al. Promotion of rat hepatocarcinogenesis by dimethylarsinic acid: association with elevated ornithine decarboxylase activity and formation of 8-hydroxydeoxyguanosine in the liver. Jpn J Cancer Res 1997; 88:1149–1154

    PubMed  CAS  Google Scholar 

  30. Glassner BJ, Rasmussen LJ, Najarian MT, Posnick LM, Samson LD. Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. Proc Natl Acad Sci USA 1998; 95:9997–10002

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported, in part, by grants from the National Institute of Environmental Health Sciences (P30 ES10126, R01 ES12686, U19 ES11391, and K22 ES11660).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Rusyn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maki, A., Kono, H., Gupta, M. et al. Predictive Power of Biomarkers of Oxidative Stress and Inflammation in Patients with Hepatitis C Virus-Associated Hepatocellular Carcinoma. Ann Surg Oncol 14, 1182–1190 (2007). https://doi.org/10.1245/s10434-006-9049-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9049-1

Keywords

Navigation